Literature DB >> 31786338

An exploratory randomized sub-study of light-to-moderate intensity exercise on cognitive function, depression symptoms and inflammation in older adults with heart failure.

Laura S Redwine1, Meredith A Pung2, Kathleen Wilson3, Katherine J Bangen4, Lisa Delano-Wood4, Barry Hurwitz5.   

Abstract

OBJECTIVE: Almost half of patients with heart failure (HF) have cognitive impairment. While exercise relates to better cognitive health, a hallmark of HF is exercise intolerance. The study objective was to explore whether light-to-moderate exercise improves cognitive function in patients with HF.
METHODS: This was an exploratory parallel design study of 69 patients with symptomatic HF (mean age = 65, SD = 10), recruited from VA and University of California, San Diego Healthcare Systems. Participants were randomized to Tai Chi (TC) (n = 24), resistance band (RB) exercise (n = 22) or treatment as usual (TAU) (n = 23). The primary outcome was change in Montreal Cognitive Assessment (MoCA) scores. We further explored if changes in Beck Depression Inventory - IA (BDI-IA) scores or inflammation biomarkers, CRP, TNFα and IL-6 related to altered cognitive function.
RESULTS: There was a fixed effect of group for MoCA scores changes (F = 8.07, p = .001). TC and RB groups had greater MoCA score increases versus TAU, but no differences were found between TC and RB. Depression symptom changes predicted altered MoCA scores (ΔR2 = 0.15, Β = -0.413, p = .001). However, group did not interact with depression symptom levels for MoCA alterations (p = .392). Changes in CRP levels predicted MoCA scores (ΔR2 = 0.078, Β = -0.283, p = .01), but group did not interact with CRP levels for MoCA alterations (p = .689).
CONCLUSIONS: Light-to-moderate exercises, TC and RB may improve cognitive function. However, the mechanisms remain unclear. ClinicalTrials.gov: NCT01625819.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31786338      PMCID: PMC7571258          DOI: 10.1016/j.jpsychores.2019.109883

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  46 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores.

Authors:  Nicole Carson; Larry Leach; Kelly J Murphy
Journal:  Int J Geriatr Psychiatry       Date:  2017-07-21       Impact factor: 3.485

Review 4.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

5.  Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria.

Authors:  Kannayiram Alagiakrishnan; Darren Mah; Jason R B Dyck; Ambikaipakan Senthilselvan; Justin Ezekowitz
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

6.  Cognitive deficits in chronic heart failure.

Authors:  Susan J Pressler; Usha Subramanian; David Kareken; Susan M Perkins; Irmina Gradus-Pizlo; Mary Jane Sauvé; Yan Ding; JinShil Kim; Rebecca Sloan; Heather Jaynes; Rose Mary Shaw
Journal:  Nurs Res       Date:  2010 Mar-Apr       Impact factor: 2.381

Review 7.  Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials.

Authors:  Michael V Fedewa; Elizabeth D Hathaway; Christie L Ward-Ritacco
Journal:  Br J Sports Med       Date:  2016-07-21       Impact factor: 13.800

8.  Cognitive Function in Heart Failure Is Associated With Nonsomatic Symptoms of Depression But Not Somatic Symptoms.

Authors:  Misty A W Hawkins; Mary A Dolansky; Julie T Schaefer; Michael J Fulcher; John Gunstad; Joseph D Redle; Richard Josephson; Joel W Hughes
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

9.  Exercise training in older patients with systolic heart failure: adherence, exercise capacity, inflammation and glycemic control.

Authors:  Eva Prescott; Rasmus Hjardem-Hansen; Flemming Dela; Ane S Teisner; Henrik Nielsen
Journal:  Scand Cardiovasc J       Date:  2009-08       Impact factor: 1.589

10.  Hyponatremia, Cognitive Function, and Mobility in an Outpatient Heart Failure Population.

Authors:  Monirah Albabtain; Michael J Brenner; John M Nicklas; Scott L Hummel; Michael P McCormick; Jeffrey L Pawlowski; Tami L Remington; Tanya R Gure; Michael P Dorsch; Barry E Bleske
Journal:  Med Sci Monit       Date:  2016-12-18
View more
  4 in total

Review 1.  Cognitive Dysfunction in Heart Failure: Pathophysiology and Implications for Patient Management.

Authors:  Sylvia Ye; Quan Huynh; Elizabeth L Potter
Journal:  Curr Heart Fail Rep       Date:  2022-08-13

2.  Cardiac rehabilitation for older adults: current evidence and future potential.

Authors:  Maha A Alfaraidhy; Claire Regan; Daniel E Forman
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-02-13

Review 3.  Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions.

Authors:  Mengxi Yang; Di Sun; Yu Wang; Mengwen Yan; Jingang Zheng; Jingyi Ren
Journal:  Front Cardiovasc Med       Date:  2022-02-07

Review 4.  Effects of Resistance Training on C-Reactive Protein and Inflammatory Cytokines in Elderly Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Sang-Dol Kim; Young-Ran Yeun
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.